Hypermarcas (OTCMKTS:HYPMY) Stock Price Passes Below 50-Day Moving Average – What’s Next?

Hypermarcas (OTCMKTS:HYPMY) shares crossed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $4.20 and traded as low as $4.16. Hypermarcas shares last traded at $4.16, with a volume of 867 shares traded.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised shares of Hypermarcas to a “hold” rating in a research note on Wednesday, April 29th. One investment analyst has rated the stock with a Hold rating, According to MarketBeat.com, the company currently has an average rating of “Hold”.

Hypermarcas Trading Up 1.9%

The business’s 50-day simple moving average is $4.20 and its two-hundred day simple moving average is $4.39. The company has a market capitalization of $2.93 billion, a PE ratio of 8.67 and a beta of 0.71.

Hypermarcas (OTCMKTS:HYPMY) last announced its earnings results on Wednesday, April 29th. The company reported $0.10 earnings per share (EPS) for the quarter. Hypermarcas had a return on equity of 14.08% and a net margin of 19.41%.The business had revenue of $383.13 million for the quarter. On average, analysts forecast that Hypermarcas will post 0.53 EPS for the current year.

Hypermarcas Company Profile

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.